Akari Therapeutics Plc

Most Recent

Company & Industry Overviews
Why Akari Therapeutics Soared Yesterday
The 12-month consensus recommendation for Akari Therapeutics is a “strong buy.”

By Margaret PatrickMar. 14 2019, Published 8:04 a.m. ET

ABOUT Market Realist
About Us
Privacy Policy
Terms of Use
DMCA

CONNECT with Market Realist

© Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.

Akari Therapeutics Plc

Why Akari Therapeutics Soared Yesterday